SAB Biotherapeutics annual ebitda margin
2020
2021
2022
2023
2024
SAB Biotherapeutics EBITDA Margin Growth & History (SABS)
SAB Biotherapeutics's ebitda margin was −2,889.02% for fiscal 2024.
View full SAB Biotherapeutics company overviewSAB Biotherapeutics annual ebitda margin history
| Fiscal year | Period ended | EBITDA margin | Change (percentage points) |
|---|---|---|---|
| 2024 | 2024-12-31 | −2,889.02% | −1351.63 pp |
| 2023 | 2023-12-31 | −1,537.40% | −1429.68 pp |
| 2022 | 2022-12-31 | −107.71% | −88.16 pp |
| 2021 | 2021-12-31 | −19.56% | −57.46 pp |
| 2020 | 2020-12-31 | 37.91% | — |
SAB Biotherapeutics quarterly ebitda margin
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q4.24
| Fiscal quarter | Period ended | EBITDA margin | Change (percentage points) |
|---|---|---|---|
| Q4 2024 | 2024-12-31 | −7,991.52% | −2083.84 pp |
| Q2 2024 | 2024-06-30 | −3,496.92% | +3024.06 pp |
| Q1 2024 | 2024-03-31 | −998.08% | +121.10 pp |
| Q4 2023 | 2023-12-31 | −5,907.68% | −5585.27 pp |
| Q3 2023 | 2023-09-30 | −341.10% | −148.40 pp |
| Q2 2023 | 2023-06-30 | −6,520.99% | −6429.77 pp |
| Q1 2023 | 2023-03-31 | −1,119.18% | −1067.74 pp |
| Q4 2022 | 2022-12-31 | −322.41% | −261.64 pp |
| Q3 2022 | 2022-09-30 | −192.70% | −168.03 pp |
| Q2 2022 | 2022-06-30 | −91.22% | −76.87 pp |
| Q1 2022 | 2022-03-31 | −51.44% | −57.64 pp |
| Q4 2021 | 2021-12-31 | −60.77% | — |
| Q3 2021 | 2021-09-30 | −24.67% | — |
| Q2 2021 | 2021-06-30 | −14.35% | — |
| Q1 2021 | 2021-03-31 | 6.20% | — |
SAB Biotherapeutics ebitda margin trends
Between the periods ended 2020-12-31 and 2024-12-31, SAB Biotherapeutics's ebitda margin decreased from 37.91% to −2,889.02%, a change of −2926.93 percentage points. The latest reported quarter, Q4 2024, shows −7,991.52%.
About the metric
What EBITDA margin means
EBITDA margin measures EBITDA as a percentage of revenue. It can help compare operating profitability over time, but it excludes capital intensity, financing costs, taxes, and other items and is generally unsuitable for financial companies.
Calculation and source
How EBITDA margin is calculated
TickerStat calculates EBITDA margin as EBITDA divided by positive reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review SAB Biotherapeutics source filings ↗